| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_093ddb01a602390c140869a56a2b5f52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0662262f76aed47126ddcf6353b38099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a07ff04a47e4b7dc43833a8d09919d0 |
| publicationDate |
2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-100379404-C |
| titleOfInvention |
Liposome composition for reduction of liposome-induced complement activation |
| abstract |
A method for reducing complement activation upon in vivo administration of a liposome preparation containing an entrapped therapeutic agent is described. The method involves providing liposomes having a polyethylene-glycol-derived neutral lipopolymer. |
| priorityDate |
2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |